# US 2009/0270692 A1 · Combination treatment alteration methods and systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270692 A1
- Document ID: US20090270692A1
- Status: Published application
- Kind: A1
- Application number: 12/154,275
- Filed: 2008-05-21
- Published: 2009-10-29
- Earliest claimed: 2008-04-24
- Assignees: Searete LLC, a limited liability corporation of the State of Delaware
- Inventors: Roderick A. Hyde; Muriel Y. Ishikawa; Eric C. Leuthardt; Royce A. Levien; Robert W. Lord; Elizabeth A. Sweeney; Mark A. Malamud; Lowell L. Wood, JR.; Victoria Y.H. Wood
- Web page: https://patentgrep.com/patent/US20090270692A1

## CPC

- A61B 5/00: Measuring for diagnostic purposes (radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00); Identification of persons
- A61B 5/02: Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/05: Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves (measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24)
- A61B 5/08: Measuring devices for evaluating the respiratory organs
- A61B 5/24: Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B 5/411: {Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance}
- A61B 5/415: {the glands, e.g. tonsils, adenoids or thymus}
- A61B 5/418: {lymph vessels, ducts or nodes}
- A61B 5/4266: {sweat secretion}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/082: {Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath (A61B5/083, A61B5/091 take precedence)}
- A61B 5/416: {the spleen}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent.

## Claims

### Claim 1

A computer-implemented method comprising:
detecting at least one indication of bioactive agent use by an individual; and
altering an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim at position 2

2-31. (canceled)

### Claim 32

A system comprising:
means for detecting at least one indication of bioactive agent use by an individual; and
means for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 33 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual.

### Claim 34 (depends on 33)

The system of claim 33 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:
means for analyzing brain activity using at least one of near infra-red imaging, EEG, magnetoencephalography, functional magnetic resonance imaging, or computer-aided tomography.

### Claim 35 (depends on 33)

The system of claim 33 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:
means for detecting at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight modifying drug, a neurodegenerative disorder medication, or a vascular disease medication as the at least one medication.

### Claim 36 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for detecting a concentration of the bioactive agent in the individual.

### Claim 37 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for comparing a measured value of the bioactive agent in the individual to a stored baseline value of the bioactive agent for the individual to identify a differential indicative of bioactive agent use.

### Claim 38 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for detecting substance use by the individual.

### Claim 39 (depends on 38)

The system of claim 38 wherein the means for detecting substance use by the individual comprises:
means for detecting at least one of alcohol use, psychoactive drug use, tranquilizer use, methamphetamine use, or narcotic use.

### Claim 40 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for detecting a nutraceutical used by the individual.

### Claim 41 (depends on 40)

The system of claim 40 wherein the means for detecting a nutraceutical used by the individual comprises:
means for detecting at least one of a memory supplement, an anti-oxidant, a cancer preventative, or a mood-changing agent.

### Claim 42 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:
means for detecting at least one indication of bioactive agent use by at least one of a computer game participant, a social networking website participant, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

### Claim 43 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 44 (depends on 43)

The system of claim 43 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for restricting access to at least a portion of the artificial sensory experience.

### Claim 45 (depends on 43)

The system of claim 43 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for granting access to at least a portion of the artificial sensory experience.

### Claim 46 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 47 (depends on 46)

The system of claim 46 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering a color scheme of an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 48 (depends on 46)

The system of claim 46 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering at least a portion of text of an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 49 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering a sound in an artificial sensory experience.

### Claim 50 (depends on 49)

The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:
means for altering at least a portion of music in the artificial sensory experience.

### Claim 51 (depends on 49)

The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:
means for altering at least a portion of ambient noise in the artificial sensory experience.

### Claim 52 (depends on 49)

The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:
means for altering at least a portion of voice in the artificial sensory experience.

### Claim 53 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering an artificial sensory experience to enhance the efficacy of the bioactive agent.

### Claim 54 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering an artificial sensory experience to reduce a side effect of the bioactive agent.

### Claim 55 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for adding at least one of visual or audio content to the artificial sensory experience.

### Claim 56 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for deleting at least one of visual or audio content of the artificial sensory experience.

### Claim 57 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for adding content to the artificial sensory experience and deleting different content of the artificial sensory experience.

### Claim 58 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering a sensate experience to modify the at least one effect of the bioactive agent.

### Claim 59 (depends on 58)

The system of claim 58 wherein the means for altering a sensate experience to modify the at least one effect of the bioactive agent comprises:
means for altering at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus to modify the at least one effect of the bioactive agent.

### Claim 60 (depends on 32)

The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:
means for altering an artificial sensory experience implemented on a mobile device.

### Claim 61 (depends on 32)

The computer-implemented method of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:
means for detecting at least one of a pain medication, an antianxiety medication, an anti-addiction medication, an anti-obesity medication, or a mood-altering medication prescribed for the individual and altering an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 62 (depends on 32)

The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:
means for detecting an anti-depressant medication in the individual and adding at least one cheerful attribute to a virtual world experience to increase an anti-depressive effect of the anti-depressant medication.

### Claim 63

A system comprising:
circuitry for detecting at least one indication of bioactive agent use by an individual; and
circuitry for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 64

A computer program product comprising:
a signal-bearing medium bearing
one or more instructions for detecting at least one indication of bioactive agent use by an individual; and
one or more instructions for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 65 (depends on 64)

The computer program product of claim 64, wherein the signal-bearing medium includes a computer-readable medium.

### Claim 66 (depends on 64)

The computer program product of claim 64, wherein the signal-bearing medium includes a recordable medium.

### Claim 67 (depends on 64)

The computer program product of claim 64, wherein the signal-bearing medium includes a communications medium.

### Claim 68

A system comprising:
a computing device; and
instructions that when executed on the computing device cause the computing device to
detect at least one indication of bioactive agent use by an individual; and
alter an artificial sensory experience to modify at least one effect of the bioactive agent.

### Claim 69 (depends on 68)

The system of claim 68 wherein the computing device comprises:
one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

### Claim 70 (depends on 68)

The system of claim 68, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.
